Related Experiment Video
Updated: Jul 10, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Prediction of appropriate implantable cardioverter-defibrillator therapy using machine learning and routinely
Toshinori Chiba1, Serafina Wegner1, Emanuel Heil1,2,3
1Department of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.
Aims:
Risk stratification for appropriate implantable cardioverter-defibrillator (ICD) therapy remains imprecise when based on conventional clinical variables alone. We aimed to develop and geographically validate a machine-learning model that integrates routinely available clinical, electrocardiogram, and device interrogation/programming parameters, and quantify the incremental value of non-sustained ventricular tachycardia (NSVT).
Methods And Results:
We retrospectively analysed 514 ICD recipients implanted between 2020 and 2025 at two hospital sites (development cohort) and an independent cohort of 220 patients from a third site (external validation). The endpoint was appropriate ICD therapy (anti-tachycardia pacing or shock). Models were trained using nested stratified cross-validation in the development cohort, and the final refitted model was applied to the external cohort without recalibration. In the development cohort, 77/514 patients (15%) experienced appropriate ICD therapy (follow-up 404 days). A base model (histogram-based gradient boosting) excluding NSVT achieved modest discrimination [receiver operating characteristic (ROC)-area under the curve (AUC) 0.624; average precision 0.198]. Adding NSVT improved performance (ROC-AUC 0.805; average precision 0.432). Logistic regression with NSVT achieved comparable discrimination (ROC-AUC 0.78; average precision 0.43), indicating a largely NSVT-driven gain. External validation (event rate 51/220, 23%) confirmed good discrimination (ROC-AUC 0.815; average precision 0.583) with acceptable calibration (Brier score 0.137). At the pre-specified threshold of 0.16 in external validation, sensitivity was 0.78 and specificity was 0.74.
Conclusion:
A machine-learning model integrating routinely available clinical, electrocardiogram, and ICD programming/interrogation data may enable the prediction of appropriate ICD therapy with preserved performance on geographic external validation. NSVT was the dominant contributor to predictive performance across modelling approaches.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Heart Failure IV: Classification and Diagnostic Evaluation